{"disease":{"id":"head-cancer-neck","name":"head cancer neck"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04075305","title":"The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"UMC Utrecht","has_results":false},{"nct_id":"NCT04905030","title":"Education, Immigration and HPV Vaccination: an Informational Randomized Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT03896958","title":"The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"SpeciCare","has_results":false},{"nct_id":"NCT02358031","title":"A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":882,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05793151","title":"Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":532,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT04050761","title":"A Study of Nivolumab in Patients With Head and Neck Cancer.","phase":"","overall_status":"COMPLETED","enrollment_count":502,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03942380","title":"Cell-free Tumor DNA in Head and Neck Cancer Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Christian von Buchwald","has_results":false},{"nct_id":"NCT05053230","title":"A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05898789","title":"Virtual Rehabilitation for Cancer Survivors","phase":"NA","overall_status":"RECRUITING","enrollment_count":388,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT05811936","title":"The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads","phase":"NA","overall_status":"RECRUITING","enrollment_count":352,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT07173270","title":"Improved Oral Health in Head and Neck Cancer Survivors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT04429542","title":"Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":292,"lead_sponsor_name":"Bicara Therapeutics","has_results":false},{"nct_id":"NCT03569436","title":"Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread","phase":"","overall_status":"COMPLETED","enrollment_count":262,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT02589938","title":"Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":258,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT03663985","title":"FALCOn (Facteur AnthropoLogique Cancer Orl)","phase":"","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"Institut Claudius Regaud","has_results":false},{"nct_id":"NCT05979883","title":"Randomized Evaluation of Machine Learning Assisted Radiation Treatment Planning vs Standard Radiation Treatment Planning","phase":"NA","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT00568490","title":"Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04675294","title":"Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":189,"lead_sponsor_name":"ALX Oncology Inc.","has_results":false},{"nct_id":"NCT04675333","title":"Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":172,"lead_sponsor_name":"ALX Oncology Inc.","has_results":false},{"nct_id":"NCT03997968","title":"A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":169,"lead_sponsor_name":"Cyteir Therapeutics, Inc.","has_results":false},{"nct_id":"NCT02376699","title":"Safety Study of SEA-CD40 in Cancer Patients","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":159,"lead_sponsor_name":"Seagen Inc.","has_results":false},{"nct_id":"NCT06837480","title":"Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Abramson Cancer Center at Penn Medicine","has_results":false},{"nct_id":"NCT05269381","title":"Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03383094","title":"Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":126,"lead_sponsor_name":"Loren Mell, MD","has_results":false},{"nct_id":"NCT06662929","title":"Arabic PRO Measures for Head and Neck Cancer Radiotherapy.","phase":"","overall_status":"RECRUITING","enrollment_count":125,"lead_sponsor_name":"King Saud University","has_results":false},{"nct_id":"NCT05576974","title":"A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT03340038","title":"Use of a Non-ICU Specialty Ward For Immediate Post-operative Management of Head and Neck Free Flaps","phase":"NA","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT06183268","title":"Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Covenant Health Cancer Center","has_results":false},{"nct_id":"NCT07394842","title":"Longitudinal Oral Health Changes After Head and Neck Radiotherapy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT02841748","title":"A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT06532279","title":"Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":98,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT04598087","title":"Prehabilitation and Recovery After Head and Neck Cancer Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":96,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT02573493","title":"Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT04260126","title":"Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"PDS Biotechnology Corp.","has_results":false},{"nct_id":"NCT03370276","title":"Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT06366945","title":"Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":85,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07242859","title":"Rice Bran Supplementation for Radiation-Induced Oral Mucositis in Head and Neck Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Christina Milad Lobos","has_results":false},{"nct_id":"NCT03082534","title":"Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT07268092","title":"Porcine Extracellular Matrix Nerve Wrap in Neck Dissection for Head and Neck Cancer","phase":"NA","overall_status":"SUSPENDED","enrollment_count":74,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT02270814","title":"Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":74,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06869473","title":"Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":67,"lead_sponsor_name":"Gruppo Oncologico del Nord-Ovest","has_results":false},{"nct_id":"NCT02296684","title":"Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT05156060","title":"Gabapentin & Ketamine for Prevention/Treatment of Acute/Chronic Pain in Locally Advanced Head and Neck Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"Natalie Lockney","has_results":false},{"nct_id":"NCT04634825","title":"Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":62,"lead_sponsor_name":"MacroGenics","has_results":true},{"nct_id":"NCT06088381","title":"Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":61,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT03541772","title":"Evaluation of Oncoxin-Viusid® in Head and Neck Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Catalysis SL","has_results":false},{"nct_id":"NCT05789316","title":"Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT00446446","title":"PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02955290","title":"CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT06265285","title":"Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}